Fentanyl: Toxic or therapeutic? Postmortem and antemortem blood concentrations after transdermal fentanyl application

Journal of Analytical Toxicology

Volumn 36, Issue 3, 2012, Pages 182-194

  Andresen, Hilke ^a   Gullans, Annemarie ^a   Veselinovic, Michele ^a   Anders, Sven ^a   Schmoldt, Achim ^a   Iwersen Bergmann, Stefanie ^a   Mueller, Alexander ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FENTANYL; NARCOTIC AGENT;

ADULT; AGED; ARTICLE; AUTOPSY; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG INTOXICATION; DRUG STABILITY; FEMALE; HUMAN; HUMAN TISSUE; IN VIVO STUDY; MAJOR CLINICAL STUDY; MALE; RETROSPECTIVE STUDY; TREATMENT DURATION; BLOOD; CADAVER; CASE REPORT; COMPARATIVE STUDY; FORENSIC TOXICOLOGY; INTRADERMAL DRUG ADMINISTRATION; METHODOLOGY; MIDDLE AGED; TISSUE DISTRIBUTION; TRANSDERMAL PATCH;

ADMINISTRATION, CUTANEOUS; AGED; FEMALE; FENTANYL; FORENSIC TOXICOLOGY; HUMANS; MALE; MIDDLE AGED; NARCOTICS; POSTMORTEM CHANGES; TISSUE DISTRIBUTION; TRANSDERMAL PATCH;

EID: 84863566623     PISSN: 01464760     EISSN: 19452403     Source Type: Journal    
DOI: 10.1093/jat/bks005     Document Type: Article

References (50)

1. Henderson, G. (1991) Fentanyl-related deaths: Demographics, circumstances, and toxicology of 112 cases. Journal of Forensic Science, 36, 422-433.
2. Anderson, D., Muto, J. (2000) Duragesic transdermal patch: Postmortem tissue distribution of fentanyl in 25 cases. Journal of Analytical Toxicology, 24, 627-634.
3. Kuhlmann, J.J., McCaulley, R., Valouch, T., Behonick, G. (2003) Fentanyl use, misuse, and abuse: A summary of 23 postmortem cases. Journal of Analytical Toxicology, 27, 499-504.
4. Reeves, M., Ginifer, C. (2002) Fatal intravenous misuse of transdermal fentanyl. Medical Journal of Australia, 177, 552-553.
5. Ferner, R. (2008) Post-mortem clinical pharmacology. British Journal of Clinical Pharmacology, 66, 430-443.
6. Palmer, R. (2010) Fentanyl in postmortem forensic toxicology. Clinical Toxicology, 48, 771-784.
7. Lilleng, P., Mehlum, L., Bachs, L., Morild, I. (2004) Deaths after intravenous misuse of transdermal fentanyl. Journal of Forensic Science, 49, 1364-1366.
8. Kramer, C., Tawney, M. (1998) A fatal overdose of transdermally administered fentanyl. Journal of the American Osteopathic Association, 98, 385.
9. Woodall, K., Martin, T., McLellan, B. (2008) Oral abuse of fentanyl patches (Duragesic): Seven case reports. Journal of Forensic Science, 53, 222-225.
10. Coon, T., Miller, M., Kaylor, D., Jones-Spangle, K. (2005) Rectal insertion of fentanyl patches: A new route of toxicity. Annals of Emergency Medicine, 46, 437-438.
11. Marquardt, K., Tharrat, R. (1994) Inhalation abuse of fentanyl patch. Journal of Toxicology-Clinical Toxicology, 32, 75-78.
12. Klockgether-Radke, A., Gaus, P., Neumann, P. (2002) Opioidintoxikation durch transdermales Fentanyl. Anaesthesist, 51, 269-271.
13. Rose, P., Macfee, M., Boswell, M. (1993) Fentanyl transdermal system overdose secondary to cutaneous hyperthermia. Anesthesia & Analgesia, 77, 390-391.
14. Newshan, G. (1998) Heat-related toxicity with the fentanyl transdermal patch. Journal of Pain and Symptom Management, 16, 277-278.
15. Flannagan, L., Butts, J., Anderson, W. (1996) Fentanyl patches left on dead bodies-Potential source of drug for abusers. Journal of Forensic Science, 41, 320-321.
16. Kronstrand, R., Druid, H., Holmgren, P., Rajs, J. (1997) A cluster of fentanyl-related deaths among drug addicts in Sweden. Forensic Science International, 88, 185-193.
17. Smialek, J., Levine, B., Chin, L., Wu, S., Jenkins, A. (1994) A fentanyl epidemic in Maryland 1992. Journal of Forensic Science, 39, 159-164.
18. Paul, L. et al. (2009) Richtlinie der GTFCh zur Qualitätssicherung bei forensisch-toxikologischen Untersuchungen (Guidelines for quality assurance in forensic-toxicological analyses). Toxichem Krimtech, 76, 142-176.
19. Hug, C., Murphy, M. (1981) Tissue redistribution of fentanyl and termination of its effects in rats. Anaesthesiology, 55, 369-375.
20. Edinboro, L., Poklis, A., Trautmann, D., Lowry, S., Backer, R., Harvey, C. (1997) Fatal fentanyl intoxication following excessive transdermal application. Journal of Forensic Science, 42, 741-743.
21. Thompson, J., Baker, A., Bracey, A., Seningen, J., Kloss, J., Strobl, A. et al. (2007) Fentanyl concentrations in 23 postmortem cases from the Hennepin county medical examiner's office. Journal of Forensic Science, 52, 978-981.
22. Olson, K., Luckenbill, K., Thompson, J., Middleton, O., Geiselhart, R., Mills, K. et al. (2010) Postmortem redistribution of fentanyl in blood. American Journal of Clinical Pathology, 133, 447-453.
23. Jumbelic, M. (2010) Deaths with transdermal fentanyl patches. American Journal of Forensic Medicine and Pathology, 31, 18-21.
24. Martin, T., Woodall, K., McLellan, B. (2006) Fentanyl related deaths in Ontario, Canada: Toxicological findings and circumstances of death in 112 Cases (2002-2004). Journal of Analytical Toxicology, 30, 603-610.
25. Coopman, V., Cordonnier, J., Pien, K., Varenbergh, D. (2007) LC-MS/MS analysis of fentanyl and norfentanyl in a fatality due to application of multiple duragesic transdermal therapeutic systems. Forensic Science International, 169, 223-227.
26. Hallberg, P., Martén, L., Wadelius, M. (2006) Possible fluconazolefentanyl interaction-a case report. European Journal of Clinical Pharmacology, 62, 491-492.
27. Janssen Pharmaceutica and Products (2009) Pharmaceutica and products. Duragesic (fentanyl transdermal sytem) full prescribing information. Titusville, FL.
28. Latasch, L., Lüders, S. (1989) Transdermal fentanyl against postoperative pain. Acta Anaesthesiologica Belgica, 40, 113-119.
29. Bower, S. (1982) The uptake of fentanyl by erythrocytes. Journal of Pharmacy and Pharmacology, 34, 181-185.
30. Bower, S., Hull, C. (1982) Comparative pharmacokinetics of fentanyl and alfentanil. British Journal of Anaesthesia, 54, 871-877.
31. Meuldermans, W., Hurkmans, R., Heykants, J. (1982) Plasma protein binding and distribution of fentanyl, sufentanil, alfentanil and lofentanil in blood. Archives Internationales de Pharmacodynamie et Therapie, 257, 4-19.
32. Mather, L. (1983) Clinical pharmacokinetics of fentanyl and its newer derivatives. Clinical Pharmacokinetics, 8, 422-446.
33. Thompson, J., Bower, S., Liddle, A., Rowbotham, D. (1998) Perioperative pharmacokinetics of transdermal fentanyl in elderly and young adult patients. British Journal of Anaesthesia, 81, 152-154.
34. Pohland, R., Bernhard, N. (1997) Postmortem serum and tissue redistribution of fluoxetine and norfluoxetine in dogs following oral administration of fluoxetine hydrochloride (Prozac). Journal of Forensic Science, 42, 812-816.
35. Pounder, D., Hartley, A., Watmough, P. (1994) Postmortem redistribution and degradation of dothiepin. Human case studies and an animal model. American Journal of Forensic Medicine and Pathology, 15, 231-235.
36. Moriya, F., Hashimoto, Y. (1999) Redistribution of basic drugs into cardiac blood from surrounding tissues during early stages postmortem. Journal of Forensic Science, 44, 10-16.
37. Kharasch, E., Hoffer, C., Whittington, D. (2004) Influence of age on the pharmacokinetics and pharmacodynamics of oral transmucosal fentanyl citrate. Anesthesiology, 101, 738-743.
38. Scott, J., Stanski, D. (1987) Decreased fentanyl and alfentanil dose requirements with age. A simultaneous pharmacokinetic and pharmacodynamic evaluation. Journal of Pharmacology and Experimental Therapeutics, 240, 159-166.
39. Jin, M., Gock, S., Jannetto, P., Jentzen, J., Wong, S. (2005) Pharmacogenomics as molecular autopsy for forensic toxicology: Genotyping cytochrome P450 3A4*1B and 3A5*3 for 25 fentanyl cases. Journal of Analytical Toxicology, 29, 590-598.
40. Ibrahim, A., Feldmann, J., Karim, A., Kharasch, E. (2003) Simultaneous assessment of drug interactions with low- and highextraction opioids. Anaesthesiology, 98, 853-861.
41. Guitton, J., Buronfosse, T., Désage, M., Lepape, A., Brazier, J.-L., Beaune, P. (1997) Possible involvement of multiple cytochrome P450S in fentanyl and sufentanil metabolism as opposed to alfentanil. Biochemical Pharmacology, 53, 1613-1619.
42. Pounder, J., Jones, G. (1989) Post-mortem drug redistribution-A toxicological nightmare. Forensic Science International, 45, 253-263.
43. Cook, D., Braithwaite, R., Hale, K. (2000) Estimating antemortem drug concentrations from postmortem blood samples: the influence of postmortem redistribution. Journal of Clinical Pathology, 53, 282-285.
44. Suzuki, O., Watanabe, K. (2005) Postmortem redistribution of drugs, 1st edition. In Drugs and poisons in humans, Suzuki, O. (ed). Springer, Berlin, Germany.
45. Leikin, J., Watson, W. (2003) Post-mortem toxicology: What the dead can and cannot tell us. Journal of Toxicology-Clinical Toxicology, 41, 47-56.
46. Yarema, M., Becker, C. (2005) Key concepts in postmortem drug redistribution. Clinical Toxicology, 43, 235-241.
47. Luckenbill, K., Thompson, J., Middleton, O., Kloss, J., Apple, F. (2008) Fentanyl postmortem redistribution: Preliminary findings regarding the relationship among femoral blood and liver and heart tissue concentrations. Journal of Analytical Toxicology, 32, 639-643.
48. Stoeckel, H., Hengstmann, J., Schuettler, J. (1979) Pharmacokinetics of fentanyl as a possible explanation for recurrence of respiratory depression. British Journal of Anaesthesia, 51, 741-745.
49. Pounder, J., Hartley, A., Watmough, P. (1994) Postmortem redistibution and degradation of dothiepin. Human case studies and an animal model. American Journal of Forensic Medicine and Pathology, 15, 231-235.
50. Ceelen, L., De Zwart, L., Voets, M., Hillewaert, V., Monbaliu, J., Teuns, G. et al. (2011) Postmortem redistribution of fentanyl in the rabbit blood. American Journal of Forensic Medicine and Pathology. DOI: 10.1097/PAF.0b013e3181fbbb4.